Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
NCT ID: NCT01425632
Description: None
Frequency Threshold: 3
Time Frame: None
Study: NCT01425632
Study Brief: A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
TAU-284 Low TAU-284 5mg twice daily for 2 weeks None None 0 161 17 161 View
TAU-284 High TAU-284 10mg twice daily for 2 weeks None None 0 166 8 166 View
Placebo TAU-284 placebo twice daily for 2 weeks None None 0 163 15 163 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pharyngitis None Infections and infestations MedDRA 14.1 View
Epistaxis None Respiratory, thoracic and mediastinal disorders MedDRA 14.1 View
Nasopharyngitis None Infections and infestations MedDRA 14.1 View